Scholefield Barnaby R, Tijssen Janice, Ganesan Saptharishi Lalgudi, Kool Mirjam, Couto Thomaz Bittencourt, Topjian Alexis, Atkins Dianne L, Acworth Jason, McDevitt Will, Laughlin Suzanne, Guerguerian Anne-Marie
Department of Critical Care Medicine, Hospital for Sick Children, Department of Paediatrics, University of Toronto, Neurosciences and Mental Health Program, Research Institute Toronto, ON, Canada.
Western University, Department of Paediatrics, London, ON, Canada & Paediatric Critical Care Medicine, Children's Hospital, London Health Sciences Centre, London, ON, Canada.
Resuscitation. 2025 Feb;207:110483. doi: 10.1016/j.resuscitation.2024.110483. Epub 2024 Dec 30.
To evaluate the ability of blood-biomarkers, clinical examination, electrophysiology, or neuroimaging, assessed within 14 days from return of circulation to predict good neurological outcome in children following out- or in-hospital cardiac arrest.
Medline, EMBASE and Cochrane Trials databases were searched (2010-2023). Sensitivity and false positive rates (FPR) for good neurological outcome (defined as either 'no, mild, moderate disability or minimal change from baseline') in paediatric survivors were calculated for each predictor. Risk of bias was assessed using the QUIPS tool.
Thirty-five studies (2974 children) were included. The presence of any of the following had a FPR < 30% for predicting good neurological outcome with moderate (50-75%) or high (>75%) sensitivity: bilateral reactive pupillary light response within 12 h; motor component ≥ 4 on the Glasgow Coma Scale score at 6 h; bilateral somatosensory evoked potentials at 24-72 h; sleep spindles, and continuous cortical activity on electroencephalography within 24 h; or a normal brain MRI at 4-6d. Early (≤12 h) normal lactate levels (<2mmol/L) or normal s100b, NSE or MBP levels predicted good neurological outcome with FPR rate < 30% and low (<50%) sensitivity. All studies had moderate to high risk of bias with timing of measurement, definition of test, use of multi-modal tests, or outcome assessment heterogeneity.
Clinical examination, electrophysiology, neuroimaging or blood-biomarkers as individual tests can predict good neurological outcome after cardiac arrest in children. However, evidence is often low quality and studies are heterogeneous. Use of a standardised, multimodal, prognostic algorithm should be studied and is likely of added value over single modality testing.
评估在恢复循环后14天内进行的血液生物标志物、临床检查、电生理学或神经影像学检查预测儿童院外或院内心脏骤停后良好神经功能结局的能力。
检索了Medline、EMBASE和Cochrane试验数据库(2010 - 2023年)。计算了每个预测指标在儿科幸存者中预测良好神经功能结局(定义为“无、轻度、中度残疾或与基线相比变化极小”)的敏感性和假阳性率(FPR)。使用QUIPS工具评估偏倚风险。
纳入35项研究(2974名儿童)。以下任何一项指标在预测良好神经功能结局时,假阳性率<30%,敏感性为中度(50 - 75%)或高度(>75%):12小时内双侧瞳孔对光反射恢复;6小时时格拉斯哥昏迷量表运动评分≥4分;24 - 72小时双侧体感诱发电位;24小时内脑电图出现睡眠纺锤波和持续皮质活动;或4 - 6天时脑MRI正常。早期(≤12小时)乳酸水平正常(<2mmol/L)或s100b、NSE或MBP水平正常,预测良好神经功能结局时假阳性率<30%,敏感性低(<50%)。所有研究在测量时间、检测定义、多模式检测的使用或结局评估异质性方面存在中度至高偏倚风险。
临床检查、电生理学、神经影像学或血液生物标志物作为单独检测方法可预测儿童心脏骤停后的良好神经功能结局。然而,证据质量通常较低且研究具有异质性。应研究使用标准化、多模式的预后算法,其可能比单一模式检测更具附加价值。